## Abstract One of the three key enzymes encoded by the __pol__ gene of HIV is a __M__~r~ 32 000 protein called HIV integrase. This viral enzyme is involved in the integration of HIV DNA into host chromosomal DNA. There appears to be no functional equivalent of the enzyme in human cells. The bioche
Human cytomegalovirus terminase as a target for antiviral chemotherapy
✍ Scribed by Elke Bogner
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 519 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1052-9276
- DOI
- 10.1002/rmv.344
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Herpesviral DNA packaging is a complex process involving binding and cleavage of DNA containing the specific DNA‐packaging motifs, pac1 and pac2, and packaging of the resulting unit‒length genomes into preformed procapsids. This process is believed to be mediated by two packaging proteins, the terminase subunits. In the case of human cytomegalovirus the terminase consists of the proteins pUL56 and pUL89. While pUL56 (i) mediates the specific binding to pac sequences on the concatamers, (ii) provides energy for the translocation of the DNA to the procapsids and (iii) associates itself with the capsid for enabling the entry of the DNA into the procapsid, pUL89 is mainly required to effect DNA cleavage. Based on the limited efficacy of the current drugs ganciclovir, cidofovir and foscarnet, new antiviral therapeutics appear to be in demand. Inhibitors targeting pUL56 and/or pUL89 may offer an attractive alternative since mammalian cell DNA replication does not involve cleavage of concatameric DNA. Drugs targeted to terminase‐like proteins should therefore be safe and highly selective. Copyright © 2002 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract Most cellular and viral processes depend on the coordinated formation of protein–protein interactions. With a better understanding of the molecular biology and biochemistry of human viruses it has become possible to screen for and detect inhibitors with activity against specific viral f
alpha-Interferon combined with 5-fluorouracil results in significant antitumoral activity in metastatic bladder carcinoma refractory to standard MVAC chemotherapy. As a single agent, alpha-interferon is ineffective for invasive or metastatic disease, but appears to contribute to the increased respon